Trials / No Longer Available

No Longer AvailableNCT03672968

EAP_GS010_single Patient

EAP Single Patient: Safety of Bilateral Intravitreal Injection of GS010 in a Single Subject Affected With G11778A ND4 Leber Hereditary Optic Neuropathy

Status: No Longer Available
Phase: —
Study type: Expanded Access
Enrollment: —

Sponsor: GenSight Biologics · Industry
Sex: All
Age: —
Healthy volunteers: —

Summary

Expanded Access Use for a single patient of Bilateral Intravitreal Injection of GS010 in a Single Subject Affected with G11778A ND4 Leber Hereditary Optic Neuropathy

Conditions

Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber)

Interventions

Type	Name	Description
GENETIC	GS010

Timeline

First posted: 2018-09-17
Last updated: 2026-03-02

Source: ClinicalTrials.gov record NCT03672968. Inclusion in this directory is not an endorsement.